IGFBP2 and lymphangioleiomyomatosis: Interestingly, IGFBP2 immunoreactivity appears in the same LAM nodules whereas cells are positively stained with an ERα antibody (Figure 1C), suggesting that there is a positive correlation between high expression of ERα and nuclear accumulation of IGFBP2 in LAM lung nodules.